Cryoport Systems Wins 2026 BioServices Innovation of the Year Award for Industry Milestone in Advanced Therapy Logistics

We are pleased to share that Cryoport Systems was honored with the BioServices Innovation of the Year Award for the 2026 BioTech Breakthrough Awards. Our organization was recognized for being the first supply chain solutions company to receive ISO 21973 certification for advanced therapy logistics, making a meaningful impact on patient access to life-changing treatments worldwide.

The BioTech Breakthrough program recognizes industry leaders propelling major advancements in the biotechnology and life sciences industry. The program is now in its sixth year, continuing to honor industry leaders driving significant advancements in the biotechnology and life sciences industry. It receives thousands of nominations from over 15 countries, highlighting just how significant the award is for Cryoport Systems.

ISO 21973 is the first international standard created for transportation of human cells for therapeutic use. Before it was established, the industry did not have a clear framework to safeguard the reliable transportation of advanced therapies, a critical step in life-changing treatment for patients. Cryoport Systems helped to develop the ISO 21973 standard, implementing its requirements within our daily operations and across our global infrastructure to achieve improved quality and consistency in our cell and gene therapy end-to-end solutions. This, in turn, helps us support advanced therapy developers as programs progress from clinical development to global distribution.

With ISO 21973 certification, Cryoport Systems has a standardized system to better identify and reduce risks through traceability, strengthen audit readiness, and improve consistency across shipping lanes. This unified framework helps maintain product integrity during transit, establishing best practices for environmental controls, equipment reliability, communication protocols, risk management and prevention, and all other aspects of handling and transporting sensitive materials.

We know that behind every shipment of temperature-controlled critical materials, there is a patient with a story, and countless lives touched. With our award-winning commitment to elevated quality requirements in the supply chain, Cryoport Systems can safely and reliably transport therapies for patients at a pivotal time in their treatment journey.